Aker BioMarine ASA (OSL:AKBM)

Market Cap	7.39B
Revenue (ttm)	2.10B
Net Income (ttm)	1.73B
Shares Out	87.70M
EPS (ttm)	19.86
PE Ratio	4.28
Forward PE	59.38
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,875
Average Volume	19,119
Open	84.00
Previous Close	84.30
Day's Range	83.90 - 86.20
52-Week Range	42.30 - 93.30
Beta	0.71
RSI	43.38
Earnings Date	Oct 31, 2025

About Aker BioMarine ASA

Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LYSOVETA brand; and marine-origin DHA omega-3 from microalgae under the Revervia brand name, as well as advanced phospholipid technology under PL+ name. ...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2006
• Employees: 249
• Stock Exchange: Oslo Børs
• Ticker Symbol: AKBM

Financial Performance

Financial numbers in USD